Jiangsu Gdk Biological Technology Co., Ltd (SHA:688670)
19.15
+0.75 (4.08%)
At close: Mar 6, 2026
SHA:688670 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 83.42 | 70.44 | 174.73 | 36.69 |
Short-Term Investments | - | 153.55 | 361.95 | - | - |
Trading Asset Securities | - | 195.39 | 175.42 | 390.57 | 657.31 |
Cash & Short-Term Investments | 160.61 | 432.37 | 607.82 | 565.3 | 694 |
Cash Growth | -62.85% | -28.87% | 7.52% | -18.55% | 442.13% |
Accounts Receivable | - | 112.96 | 81.24 | 341.11 | 342.76 |
Other Receivables | - | 0.5 | 0.48 | 0.54 | 0.89 |
Receivables | - | 113.45 | 81.71 | 341.65 | 343.65 |
Inventory | - | 34.93 | 21.98 | 31.95 | 27.98 |
Other Current Assets | - | 1.83 | 10.74 | 12.11 | 4.08 |
Total Current Assets | - | 582.58 | 722.24 | 951.02 | 1,070 |
Property, Plant & Equipment | - | 809.46 | 794.95 | 785.9 | 523.89 |
Other Intangible Assets | - | 30.22 | 35.32 | 40.41 | 45.46 |
Long-Term Deferred Tax Assets | - | 55.81 | 33.31 | 17.75 | 21.79 |
Long-Term Deferred Charges | - | 51.36 | 42.42 | 27.81 | 15.46 |
Other Long-Term Assets | - | 3.48 | 3.36 | 3.89 | 78.19 |
Total Assets | - | 1,533 | 1,632 | 1,827 | 1,754 |
Accounts Payable | - | 25.06 | 11.48 | 9.66 | 7.52 |
Accrued Expenses | - | 62.7 | 62.87 | 144.52 | 132.36 |
Short-Term Debt | - | 47.63 | 64.06 | 42.04 | 10.01 |
Current Unearned Revenue | - | - | - | 0.05 | 0.05 |
Other Current Liabilities | - | 75.49 | 88.93 | 106.23 | 71.73 |
Total Current Liabilities | - | 210.88 | 227.34 | 302.5 | 221.68 |
Long-Term Unearned Revenue | - | 25.11 | 25.56 | 25.98 | 25.67 |
Long-Term Deferred Tax Liabilities | - | 0.09 | 0.06 | 0.09 | 0.35 |
Other Long-Term Liabilities | - | 19.25 | 7.56 | 38.54 | 45.42 |
Total Liabilities | - | 255.33 | 260.52 | 367.11 | 293.12 |
Common Stock | - | 123.2 | 123.2 | 88 | 88 |
Additional Paid-In Capital | - | 1,116 | 1,116 | 1,151 | 1,151 |
Retained Earnings | - | 38.18 | 131.68 | 220.27 | 222.73 |
Shareholders' Equity | 1,191 | 1,278 | 1,371 | 1,460 | 1,461 |
Total Liabilities & Equity | - | 1,533 | 1,632 | 1,827 | 1,754 |
Total Debt | 58.04 | 47.63 | 64.06 | 42.04 | 10.01 |
Net Cash (Debt) | 102.57 | 384.74 | 543.76 | 523.26 | 683.99 |
Net Cash Growth | -73.34% | -29.24% | 3.92% | -23.50% | - |
Net Cash Per Share | 0.83 | 3.13 | 4.44 | 4.28 | 6.52 |
Filing Date Shares Outstanding | 123.2 | 123.2 | 123.2 | 123.2 | 123.2 |
Total Common Shares Outstanding | 123.2 | 123.2 | 123.2 | 123.2 | 123.2 |
Working Capital | - | 371.7 | 494.91 | 648.52 | 848.02 |
Book Value Per Share | 9.67 | 10.37 | 11.13 | 11.85 | 11.86 |
Tangible Book Value | 1,165 | 1,247 | 1,336 | 1,419 | 1,416 |
Tangible Book Value Per Share | 9.45 | 10.12 | 10.84 | 11.52 | 11.49 |
Buildings | - | 117.03 | 107.68 | 107.22 | 107.18 |
Machinery | - | 221.67 | 206.49 | 204.15 | 196.33 |
Construction In Progress | - | 661.51 | 649.46 | 619.86 | 341.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.